US And EU Approvals In First Half 2021 Underscore US-First Orientation Of Novel Drug Development

 
• By Bridget Silverman and Neena Brizmohun
  
US & EU Approvals
Fifty-five novel products were approved in either the US or EU during the first half of 2021.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews